Alzheimer’s disease is a condition that slowly destroys memory and thinking skills. It is marked by two main changes in the brain: the build-up of amyloid plaques between brain cells and the formation ...

NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

The findings support the concept that excessive lipogenesis, rather than just fat delivery from other sources, is central to ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Apostle Dr. Kadmiel E.H. Agbelenyo, Founder and Leader of the Seventh Day Theocracy World Congregation, has called on ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Hundreds are gathering to support research and education at the Liver Life Walk, an event inspiring hope through stories of ...

At DDW 2025, researchers presented their findings on the effects of MAFLD on outcomes of patients with hepatocellular carcinoma.

A shocking new study finds the number of alcohol-related deaths in the US has nearly doubled in the last two decades.

SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...